Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BIMI Holdings's Days Sales Outstanding for the
three
months ended in Sep. 2023 was 189.81.
BIMI Holdings's Days Inventory for the
three
months ended in Sep. 2023 was 270.38.
BIMI Holdings's Days Payable for the
three
months ended in Sep. 2023 was 379.76.
Therefore, BIMI Holdings's Cash Conversion Cycle (CCC) for the
three
months ended in Sep. 2023 was 80.43.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
BIMI Holdings Cash Conversion Cycle Related Terms
BIMI Holdings Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for BIMI Holdings's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIMI vs RADCQ, HEWA, SSY: Cash Conversion Cycle Comparison
For the Pharmaceutical Retailers subindustry, BIMI Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BIMI Holdings Cash Conversion Cycle vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BIMI Holdings's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where BIMI Holdings's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
BIMI Holdings's Cash Conversion Cycle for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIMI Holdings (BIMI) has a Cash Conversion Cycle of 80.43 as of Sep. 2023. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on BIMI Holdings and its competitors.
Is BIMI Holdings' Cash Conversion Cycle too high?
BIMI Holdings' current Cash Conversion Cycle is 80.43. The Healthcare Providers & Services industry median Cash Conversion Cycle is 17.65. BIMI Holdings' value of 80.43 is 355.7% above this industry median. Overall, BIMI Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BIMI Holdings' Cash Conversion Cycle compare to RADCQ and HEWA?
BIMI Holdings' Cash Conversion Cycle of 80.43 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Conversion Cycle is 17.65. BIMI Holdings' value of 80.43 is 355.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Healthcare Providers & Services company?
The median Cash Conversion Cycle among Healthcare Providers & Services companies is 17.65, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BIMI Holdings's current Cash Conversion Cycle of 80.43 is 355.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on BIMI Holdings and its competitors. For the Healthcare Providers & Services industry, the median Cash Conversion Cycle is 17.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BIMI Holdings's current Cash Conversion Cycle is 80.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BIMI Holdings stock overvalued right now?
BIMI Holdings (BIMI) has a current Cash Conversion Cycle of 80.43. The current Cash Conversion Cycle is 80.43 and 355.7% above the Healthcare Providers & Services industry median of 17.65. BIMI Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For BIMI Holdings (BIMI), the current Cash Conversion Cycle is 80.43 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BIMI Holdings Inc is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. It operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and OTC medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. Medical services include private comprehensive hospitals operating in China.
16GF Score
Get the complete analysis for BIMI
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIMI has been successfully added to your 
